HIK
Hikma is a global pharmaceutical company that develops, manufactures, and distributes high-quality generic medicines and injectables across North America, the Middle East and North Africa (MENA), and Europe. The company focuses on making affordable medicines accessible to patients, while expanding its product portfolio through R&D and contracted manufacturing capabilities. Hikma emphasizes responsible business practices and sustainability as part of its mission to improve health and wellbeing in communities worldwide.
No recent deals for this company.